Spanish drugmaker Grifols has been awarded a $21 million grant from the Michael J Fox Foundation to support a pilot study to ...

The unique plasma assets serve as the foundation of the Chronos-PD program, driving advanced research at Grifols subsidiary Alkahest, which is leading the initiative given its specialization in the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

The Catalan blood products company has received a $21 million grant from the Michael J. Fox Foundation (MJFF) for Parkinson's ...

Grifols is anticipating a period of strong ... as well as a new bi-weekly dosing approval for Xembify and pipeline products fibrinogen and trimodulin. The drugmaker has been involved in a series ...

Spanish firm Grifols has submitted a Biologics License Application (BLA) for its new potential fibrinogen treatment to the US ...

Mason Capital denuncia ante el regulador español la "falta de transparencia" de Grifols January 13, 2025 Eli Lilly said on Monday it has sued two medical spas for selling unapproved products ...

Preliminary fourth quarter 2024 total revenue of approximately $57.6 million which includes TAVALISSE® net product s ...